{"id":4354,"date":"2019-01-30T09:50:19","date_gmt":"2019-01-30T09:50:19","guid":{"rendered":"http:\/\/www.caltagmedsystems.co.uk\/information\/?p=4354"},"modified":"2022-03-10T14:36:30","modified_gmt":"2022-03-10T14:36:30","slug":"clinically-relevant-mesenchymal-stem-cell-populations-for-research","status":"publish","type":"post","link":"https:\/\/www.caltagmedsystems.co.uk\/information\/clinically-relevant-mesenchymal-stem-cell-populations-for-research\/","title":{"rendered":"Clinically Relevant Mesenchymal Stem Cell Populations for Research"},"content":{"rendered":"<p><a href=\"https:\/\/www.caltagmedsystems.co.uk\/renovos\/?utm_source=email&amp;utm_campaign=Renovos_Launch_Feb_2019&amp;utm_medium=email\">Renovos<\/a> offer unique Bone Marrow Mesenchymal Stem Cells (MSCs), which have been isolated from patients with Osteoarthritis. Renovos provide heterogeneous populations of MSCs for biologics and biomaterial testing.<\/p>\n<p>By applying clonal culture techniques, <a href=\"https:\/\/www.caltagmedsystems.co.uk\/renovos\/?utm_source=email&amp;utm_campaign=Renovos_Launch_Feb_2019&amp;utm_medium=email\">Renovos<\/a> MSCs are supplied at the highest purity and at an early passage, allowing for cell expansion.<\/p>\n<p>Renovos stem cells offer the following key advantages:<br \/>\n\u2022 Clinically relevant age range for testing therapeutics\/biomaterials designed for the elderly, adults or adolescents<br \/>\n\u2022 Donors with clinical presentations -osteoarthritis; as a suitable model for relevant drug\/biomaterial testing<br \/>\n\u2022 Early passages and guaranteed cell expansion &#8211; P2 stocks, &gt;10 population doublings under optimal conditions<br \/>\n\u2022 Detailed flow cytometric analysis &#8211; for expression of common mesenchymal stem\/progenitor cell markers, including for STRO-1, CD73, CD90, CD105<br \/>\n\u2022 Multipotency &#8211; tested for osteo-, chondro- and adipogenic differentiation in vitro<br \/>\n\u2022 Pathogen free &#8211; HBV\/HCV\/HIV, bacteria, mycoplasma and fungi free<br \/>\n\u2022 Various levels of purity of the stem cell populations available upon request: unselected mesenchymal, STRO-1 cell-enriched, Clonal<br \/>\n\u2022 Inventory available upon request, detailing lot availability, donor age and sex.<br \/>\n\u2022 Lot specific Certificate of Analysis are also available to view.<br \/>\n\u2022 Next day delivery available.<\/p>\n<p>Currently, the following products are available:<br \/>\n<a href=\"https:\/\/www.caltagmedsystems.co.uk\/pricing_ordering\/product_detail.php?CI_ID=1032518&amp;utm_source=email&amp;utm_campaign=Renovos_Launch_Feb_2019&amp;utm_medium=email\">Bone Marrow Mesenchymal Stem Cells &#8211; Osteoarthritic, 500,000 Cells<\/a><br \/>\nProduct Code: REN-OA-500<\/p>\n<p><a href=\"https:\/\/www.caltagmedsystems.co.uk\/pricing_ordering\/product_detail.php?CI_ID=1032519&amp;utm_source=email&amp;utm_campaign=Renovos_Launch_Feb_2019&amp;utm_medium=email\">Bone Marrow Mesenchymal Stem Cells &#8211; Osteoarthritic, 1 million Cells<\/a><br \/>\nProduct Code: REN-OA-1M<\/p>\n<p>Please do <a href=\"mailto:techsupport@caltagmedsystems.co.uk?subject=Renovos%20MSC%20Enquiry\">contact us<\/a> if you require MSCs from an alternate disease state, as we may be able to provide a custom product.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Renovos offer unique Bone Marrow Mesenchymal Stem Cells (MSCs), which have been isolated from patients with Osteoarthritis. Renovos provide heterogeneous populations of MSCs for biologics and biomaterial testing. By applying clonal culture techniques, Renovos MSCs are supplied at the highest<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,18,474],"tags":[],"class_list":["post-4354","post","type-post","status-publish","format-standard","hentry","category-blood-products","category-cell-culture","category-stem-cells-2"],"_links":{"self":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/4354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/comments?post=4354"}],"version-history":[{"count":1,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/4354\/revisions"}],"predecessor-version":[{"id":4355,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/4354\/revisions\/4355"}],"wp:attachment":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media?parent=4354"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/categories?post=4354"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/tags?post=4354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}